INIS
cancer
100%
inflammation
100%
death
100%
ligands
100%
breasts
100%
carcinomas
36%
patients
27%
antibodies
18%
tissues
9%
receptors
9%
therapy
9%
multivariate analysis
9%
lethals
9%
detection
9%
estrogens
9%
melanomas
9%
lung cells
9%
food and drug administration
9%
Medicine and Dentistry
Programmed Death 1 Ligand 1
100%
Inflammatory Breast Cancer
100%
Overall Survival
36%
Patient
27%
Antibody
18%
Therapeutic Procedure
9%
Breast Cancer
9%
Survival Rate
9%
Multivariate Analysis
9%
Nodular Melanoma
9%
Estrogen Receptor
9%
Univariate Analysis
9%
Non Small Cell Lung Cancer
9%
Tissue Microarray
9%
Pharmacology, Toxicology and Pharmaceutical Science
Programmed Death 1 Ligand 1
100%
Inflammatory Breast Cancer
100%
Overall Survival
36%
Antibody
18%
Breast Cancer
9%
Estrogen Receptor
9%
Survival Rate
9%
Melanoma
9%
Non Small Cell Lung Cancer
9%
Keyphrases
Inflammatory Breast Carcinoma
66%
Triple-negative Status
16%